{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:59:06Z","timestamp":1792180746501,"version":"4.4.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3,30]]},"DOI":"10.1097\/qad.0b013e3282f560d9","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T17:52:13Z","timestamp":1236275533000},"page":"707-715","source":"Crossref","is-referenced-by-count":65,"title":["Association of antiretroviral therapy with fibrinogen levels in HIV-infection"],"prefix":"10.1097","volume":"22","author":[{"given":"Erin","family":"Madden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P","family":"Kotler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora E","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Heymsfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Grunfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210130","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00126334-200308010-00012","article-title":"Coronary heart disease in HIV-infected individuals","volume":"33","author":"Currier","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R2-5-20210130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00126334-200208150-00002","article-title":"Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?","volume":"30","author":"Klein","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-5-20210130","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-Moller","year":"2007","journal-title":"N Engl J Med"},{"key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1097\/01.aids.0000247115.81832.a1","article-title":"Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use","volume":"20","author":"Kwong","year":"2006","journal-title":"AIDS"},{"key":"R5-5-20210130","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s11745-005-1488-8","article-title":"Overview of hemostatic factors involved in atherosclerotic cardiovascular disease","volume":"40","author":"Kannel","year":"2005","journal-title":"Lipids"},{"key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00041433-199910000-00008","article-title":"Inflammation markers and coronary heart disease","volume":"10","author":"Tracy","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"R7-5-20210130","first-page":"1799","article-title":"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis","volume":"294","author":"Danesh","year":"2005","journal-title":"JAMA"},{"key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00042560-200204150-00003","article-title":"Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy","volume":"29","author":"Koppel","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-5-20210130","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000182230.47819.aa","article-title":"Fat distribution in men with HIV infection","volume":"40","author":"Bacchetti","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R12-5-20210130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000083816","article-title":"Adipose tissue and atherothrombosis","volume":"33","author":"Alessi","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"R13-5-20210130","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.metabol.2003.12.009","article-title":"Body fat is the main predictor of fibrinogen levels in healthy nonobese men","volume":"53","author":"Bo","year":"2004","journal-title":"Metabolism"},{"key":"R14-5-20210130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjcard.2005.02.051","article-title":"Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women","volume":"96","author":"Piche","year":"2005","journal-title":"Am J Cardiol"},{"key":"R15-5-20210130","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0895-4356(88)90080-7","article-title":"CARDIA: study design, recruitment, and some characteristics of the examined subjects","volume":"41","author":"Friedman","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"R16-5-20210130","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/aje\/kwj111","article-title":"The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics","volume":"163","author":"Tien","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R17-5-20210130","first-page":"E249","article-title":"Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass","volume":"275","author":"Gallagher","year":"1998","journal-title":"Am J Physiol"},{"key":"R18-5-20210130","article-title":"Generalized additive models","author":"Hastie","year":"1990"},{"key":"R19-5-20210130","article-title":"An introduction to the boostrap","author":"Efron","year":"1993"},{"key":"R20-5-20210130","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1086\/505974","article-title":"Single-dose lopinavir\/ritonavir acutely inhibits insulin-mediated glucose disposal in healthy normal volunteers","volume":"43","author":"Lee","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R21-5-20210130","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/QAD.0b013e32826fbc54","article-title":"Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers","volume":"21","author":"Lee","year":"2007","journal-title":"AIDS"},{"key":"R22-5-20210130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00002030-200403050-00008","article-title":"The metabolic effects of lopinavir\/ritonavir in HIV-negative men","volume":"18","author":"Lee","year":"2004","journal-title":"AIDS"},{"key":"R23-5-20210130","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/00002030-200105040-00001","article-title":"Metabolic effects of indinavir in healthy HIV-seronegative men","volume":"15","author":"Noor","year":"2001","journal-title":"AIDS"},{"key":"R24-5-20210130","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200411050-00005","article-title":"The effects of HIV protease inhibitors atazanavir and lopinavir\/ritonavir on insulin sensitivity in HIV-seronegative healthy adults","volume":"18","author":"Noor","year":"2004","journal-title":"AIDS"},{"key":"R25-5-20210130","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/01.aids.0000244200.11006.55","article-title":"Effects of atazanavir\/ritonavir and lopinavir\/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically","volume":"20","author":"Noor","year":"2006","journal-title":"AIDS"},{"key":"R26-5-20210130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-200001070-00006","article-title":"Effect of ritonavir on lipids and postheparin lipase activities in normal subjects","volume":"14","author":"Purnell","year":"2000","journal-title":"AIDS"},{"key":"R27-5-20210130","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.1987.03400090067035","article-title":"Fibrinogen and risk of cardiovascular disease. The Framingham Study","volume":"258","author":"Kannel","year":"1987","journal-title":"JAMA"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200803300-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:05:31Z","timestamp":1618038331000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200803300-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,30]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3282f560d9","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3,30]]}}}